Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids

Foot and mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals, which causes severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). Although inactivated virus vaccines have proved to be effective in FMD control,...

Full description

Bibliographic Details
Main Authors: Mignaqui, Ana Clara, Ruiz, Vanesa, Durocher, Yves, Wigdorovitz, Andres
Format: Artículo
Language:Inglés
Published: Taylor & Francis 2019
Subjects:
Online Access:http://hdl.handle.net/20.500.12123/5149
https://www.tandfonline.com/doi/abs/10.1080/07388551.2018.1554619?journalCode=ibty20
https://doi.org/10.1080/07388551.2018.1554619
_version_ 1855483564688146432
author Mignaqui, Ana Clara
Ruiz, Vanesa
Durocher, Yves
Wigdorovitz, Andres
author_browse Durocher, Yves
Mignaqui, Ana Clara
Ruiz, Vanesa
Wigdorovitz, Andres
author_facet Mignaqui, Ana Clara
Ruiz, Vanesa
Durocher, Yves
Wigdorovitz, Andres
author_sort Mignaqui, Ana Clara
collection INTA Digital
description Foot and mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals, which causes severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). Although inactivated virus vaccines have proved to be effective in FMD control, they have a number of disadvantages, including the need for high bio-containment production facilities and the lack of induction of immunological memory. Novel FMD vaccines based on the use of recombinant empty capsids have shown promising results. These recombinant empty capsids are attractive candidates because they avoid the use of virus in the production facilities but conserve its complete repertoire of conformational epitopes. However, many of these recombinant empty capsids require time-consuming procedures that are difficult to scale up. Achieving production of a novel and efficient FMD vaccine requires not only immunogenic antigens, but also industrially relevant processes. This review intends to summarize and compare the different strategies already published for the production of FMDV recombinant empty capsids, focusing on large-scale production.
format Artículo
id INTA5149
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2019
publishDateRange 2019
publishDateSort 2019
publisher Taylor & Francis
publisherStr Taylor & Francis
record_format dspace
spelling INTA51492024-07-11T10:31:30Z Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids Mignaqui, Ana Clara Ruiz, Vanesa Durocher, Yves Wigdorovitz, Andres Aphthovirus Vaccines Viruses Virus Fiebre Aftosa Vacuna Virus Foot and mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals, which causes severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). Although inactivated virus vaccines have proved to be effective in FMD control, they have a number of disadvantages, including the need for high bio-containment production facilities and the lack of induction of immunological memory. Novel FMD vaccines based on the use of recombinant empty capsids have shown promising results. These recombinant empty capsids are attractive candidates because they avoid the use of virus in the production facilities but conserve its complete repertoire of conformational epitopes. However, many of these recombinant empty capsids require time-consuming procedures that are difficult to scale up. Achieving production of a novel and efficient FMD vaccine requires not only immunogenic antigens, but also industrially relevant processes. This review intends to summarize and compare the different strategies already published for the production of FMDV recombinant empty capsids, focusing on large-scale production. Instituto de Virología Fil: Mignaqui, Ana Clara. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Ruiz, Vanesa. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Durocher, Yves. National Research Council Canada. Human Health Therapeutics Research Center; Canadá Fil: Wigdorovitz, Andres. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina 2019-05-20T11:02:30Z 2019-05-20T11:02:30Z 2019-05 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/5149 https://www.tandfonline.com/doi/abs/10.1080/07388551.2018.1554619?journalCode=ibty20 1549-7801 https://doi.org/10.1080/07388551.2018.1554619 eng info:eu-repograntAgreement/INTA/PNSA/1115052/AR./Epidemiología y desarrollo de estrategias para la prevención y control de enfermedades que afectan la salud pública, enfermedades exóticas y limitantes del comercio internacional. info:eu-repo/semantics/restrictedAccess application/pdf Taylor & Francis Critical Reviews in Biotechnology 39 (3) : 306-320 (Mayo 2019)
spellingShingle Aphthovirus
Vaccines
Viruses
Virus Fiebre Aftosa
Vacuna
Virus
Mignaqui, Ana Clara
Ruiz, Vanesa
Durocher, Yves
Wigdorovitz, Andres
Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title_full Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title_fullStr Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title_full_unstemmed Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title_short Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
title_sort advances in novel vaccines for foot and mouth disease focus on recombinant empty capsids
topic Aphthovirus
Vaccines
Viruses
Virus Fiebre Aftosa
Vacuna
Virus
url http://hdl.handle.net/20.500.12123/5149
https://www.tandfonline.com/doi/abs/10.1080/07388551.2018.1554619?journalCode=ibty20
https://doi.org/10.1080/07388551.2018.1554619
work_keys_str_mv AT mignaquianaclara advancesinnovelvaccinesforfootandmouthdiseasefocusonrecombinantemptycapsids
AT ruizvanesa advancesinnovelvaccinesforfootandmouthdiseasefocusonrecombinantemptycapsids
AT durocheryves advancesinnovelvaccinesforfootandmouthdiseasefocusonrecombinantemptycapsids
AT wigdorovitzandres advancesinnovelvaccinesforfootandmouthdiseasefocusonrecombinantemptycapsids